INTERNATIONAL PATENT: LIGACHEM BIOSCIENCES INC. FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATE COMPRISING BISPECIFIC ANTIBODY SPECIFICALLY BINDING TO CD20 AND CD22 AND USES THEREOF"

GENEVA, May 18 -- LIGACHEM BIOSCIENCES INC. (10, Gukjegwahak 10-roYuseong-guDaejeon 34002) filed a patent application (PCT/IB2024/000636) for "ANTIBODY-DRUG CONJUGATE COMPRISING BISPECIFIC ANTIBODY SPECIFICALLY BINDING TO CD20 AND CD22 AND USES THEREOF" on Nov 08, 2024. With publication no. WO/2025/099489, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIM, Wihak (10, Gukjegwahak 10-roYuseong-guDaejeon 34002), OH, Hwan Hee (10, Gukjegwahak 10-roYuseong-guDaejeon 34002), SONG, Ho Young (10, Gukjegwahak 10-roYuseong-guDaej...